BRAF V600E

Clinical trials for BRAF V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E trials appear

Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets Hard-to-Treat cancers with KRAS and BRAF mutations

Disease control Recruiting now

This early-phase study tests an oral drug called S241656 in adults with advanced cancers that have specific genetic changes (KRAS, BRAF, or other RAS/MAPK mutations). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrin…

Matched conditions: BRAF V600E

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

BRAF V600E

Get alerted when new BRAF V600E trials appear

New pill targets Hard-to-Treat cancers with KRAS and BRAF mutations